Background illustration for clinical trials search

Paid Clinical Trials Tampa

Discover 1,443 paid clinical trials in Tampa, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors

for
Colorectal Cancer, Triple Negative Breast Cancer,
Location: Tampa FL, Atlanta GA, Baton Rouge LA, Nashville TN,
Sponsor: OncXerna Theraputics, Inc.

Sex: All

Age: 18+

Code: NCT05453825

Phase2, Recruiting

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

for
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06104592

Phase2, Recruiting

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Tampa FL, Miami FL, Columbus OH, St Louis MO,
Sponsor: Syncromune, Inc.

Sex: Male

Age: 18+

Code: NCT06533644

Phase2, Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

for
Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor,
Location: Tampa FL, Atlanta GA, Nashville TN, Charlottesville VA,
Sponsor: Xencor, Inc.

Sex: All

Age: 15+

Code: NCT06276491

Phase1, Recruiting

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Male

Age: 18+

Code: NCT06193486

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

for
Hormone Receptor-positive Breast Cancer,
Location: Tampa FL, Nashville TN, Fairfax VA, Dallas TX,
Sponsor: Ellipses Pharma

Sex: Female

Age: 18+

Code: NCT05573126

Phase1, Phase2, Recruiting

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Tampa FL, Atlanta GA, Houston TX, New York NY,
Sponsor: Orca Biosystems, Inc.

Sex: All

Age: 12 - 70+

Code: NCT03802695

Phase1, Recruiting

Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

for
Diffuse Large B Cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05757219

Phase2, Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06144606

Phase2, Recruiting

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

for
Breast Cancer, Node-positive Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06833502

Phase2, Recruiting

Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

for
Oral Mucositis
Location: Tampa FL, Gainesville FL, Durham NC, Houston TX,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT00901732

Phase1, Phase2, Recruiting

Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym

for
Large B-cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06760156

Phase2, Recruiting
New

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

for
Peritoneal Carcinomatosis
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07487168

Phase1, Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

for
LGLL - Large Granular Lymphocytic Leukemia,
Location: Tampa FL, Birmingham AL, Charlottesville VA, Houston TX,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT05475925

Phase1, Phase2, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Tampa FL, St. Petersburg FL, Boca Raton FL, Macon GA,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase3, Recruiting

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

for
Rett Syndrome
Location: Tampa FL, Houston TX, Baltimore MD, Chicago IL,
Sponsor: Biomed Industries, Inc.

Sex: Female

Age: 5 - 20

Code: NCT06840496

Phase3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Tampa FL, Clermont FL, Kissimmee FL, Orlando FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase3, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

for
Acne
Location: Brandon FL, Jacksonville FL, New Orleans LA, Encino CA
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT07013747

Phase1, Phase2, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Tampa FL, Kissimmee FL, Fort Myers FL, Miami FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07185009

Phase3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Tampa FL, Clermont FL, Kissimmee FL, Orlando FL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase3, Recruiting